CS Capital

Baiying Bio is a research and development outsourcing service provider.

Laekna Therapeutics Shanghai Co., Ltd. is a gene therapy company, which develops therapeutics for oncology and metabolic diseases. It develops pre-clinical discovery programs for oncology and liver diseases. It develops small molecule candidate LAE001 (previously known as CFG920) for prostate cancer. The company was founded in 2016 and is based in Shanghai, China.

InxMed (Nanjing) Co., Ltd. is a clinical-stage biotechnology company based in Nanjing, China, with additional offices in Beijing, Shanghai, and Sydney, Australia. Founded in 2018, InxMed focuses on the research and development of innovative treatment options for patients, particularly in oncology. The company is working on several drug candidates, including IN10018, a selective ATP-competitive focal adhesion kinase (FAK) small molecule inhibitor for cancer treatment, INX0001 for liver and colorectal cancer, and various other programs such as IN30101. By emphasizing a deep understanding of disease biology and pharmacology, InxMed aims to develop "Best-in-Disease Combination" medicines that address unmet medical needs.

G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc).

Tavotek Biotherapeutics is a biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutic medicines for patients with severe diseases that lack effective treatments. The company is led by experienced pharmaceutical executives who have successfully developed numerous biologics currently on the market. Tavotek employs three distinct research and development platforms: TavoSelect, an innovative Phage Display Library; TavoPrecise, an engineering platform for tissue-specific biologics; and TavoMIP, a multicyclic peptide platform. This diverse array of technologies supports Tavotek's extensive pipeline of product candidates, which targets cancers, autoimmune disorders, and infectious diseases, thereby addressing significant unmet medical needs in the healthcare landscape.

Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents. The company was founded in 2012 and is headquartered in Shanghai, China.

Eighteeth focuses on the research and production of dental instruments. Eighteeth has 14 product categories including endo motor, apex locator, ultrasonic scaler, curing light, X-Ray unit, intraoral sensor, intraoral scanner, and owns 110 authorized patents.

Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.

Cipher Gene (Beijing) Co., Ltd. is a biotechnology company that specializes in the analysis of large-scale genetic data and precision medical services. Founded in 2015 and headquartered in Beijing, China, with additional offices in Suzhou, Nanjing, and Lewes, Delaware, the company develops a biomedical big data analysis platform designed for the interpretation of genomic and multi-omics data. Cipher Gene focuses on discovering biomarkers for various diseases and offers genetic testing products related to inherited diseases and cancer. Its services include experimental design assistance, data analysis, and interpretation support for third-party research institutions, universities, and hospitals. The company employs artificial intelligence technologies to enhance the accuracy and efficiency of genetic diagnostics, thereby enabling physicians to make informed treatment decisions. Through collaborations with clinical laboratories, Cipher Gene aims to advance precision medicine and personalized healthcare.

Beijing Tuorui Detection Technology Co., Ltd. provides research and development of animal disease diagnostics and testing products. It was founded in 2013 and is based in China.